# Nuclide record matthias-eiber (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/matthias-eiber/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "matthias-eiber" ;
  schema:name "Matthias Eiber"@en ;
  schema:description "A German nuclear medicine physician whose 2015 study of gallium-68 PSMA PET scanning for prostate cancer became one of the most-cited papers in the field, and who now leads theranostics research in Munich."@en ;
  schema:url <https://nuclide.cc/people/matthias-eiber/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://nuklearmedizin.mri.tum.de/de/lebenslauf-prof-dr-med-matthias-eiber>, <https://jnm.snmjournals.org/content/56/5/668> ;
  nuclide:tag "PSMA", "PET", "clinician" ;
  schema:jobTitle "Professor and Head of the Theranostics Section, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich" ;
  nuclide:related <https://nuclide.cc/drugs/ga68-psma-11/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/institutions/tum-munich/>, <https://nuclide.cc/trials/psmaddition/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/> ;
  schema:affiliation <https://nuclide.cc/institutions/tum-munich/> .